DEUTSCHE BANK AG\ - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 41 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$90,191
+517.0%
15,235
+673.4%
0.00%
Q2 2023$14,617
-92.8%
1,970
-92.5%
0.00%
Q4 2020$204,000
-55.7%
26,166
-45.0%
0.00%
Q3 2020$461,00047,5990.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Interchange Capital Partners, LLC 11,420$90,0000.14%
GSA CAPITAL PARTNERS LLP 47,097$373,0000.04%
GOODWIN DANIEL L 10,000$80,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 99,166$784,0000.01%
EMFO, LLC 1,666$13,0000.01%
PINNACLE ASSOCIATES LTD 34,333$272,0000.01%
BLAIR WILLIAM & CO/IL 51,466$407,0000.00%
Tarbox Family Office, Inc. 332$3,0000.00%
Hartford Financial Management Inc. 598$5,0000.00%
Tower Research Capital LLC (TRC) 3,808$30,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders